Table 4 Multivariate logistic regression for independent factors associated with total mg concentrations and clinical outcomes (n = 500).

From: Prevalence, clinical characteristics, and health outcomes of dysmagnesemia measured by ionized and total body concentrations among medically hospitalized patients

Outcome tested in the model

Independent factors

aOR* [95% CI]

p-value

Transfers to High Dependency Unit

Total Mg concentration

4.34 [1.24–15.06]

0.02

Frusemide

3.09 [1.99–4.79]

< 0.01

Cardiac arrest

Total Mg concentration

14.64 [3.04–70.57]

< 0.01

Female

0.48 [0.24–0.95]

0.04

Albumin mmol/L

0.93 [0.88–0.96]

< 0.01

Frusemide

3.29 [1.61–6.72]

< 0.01

6-month mortality

Total Mg concentration

11.44 [2.46–53.17]

< 0.01

Albumin mmol/L

0.89 [0.85–0.93]

< 0.01

Frusemide

1.91 [1.04–3.51]

0.04

Age

1.03 [1.01–1.05]

< 0.01

Hypermagnesemia verses Hypomagnesemia

Potassium, IQR, mmol/L

1.73 [1.10–2.72]

< 0.01

Sodium, IQR, mmol/L

1.07 [1.02–1.11]

< 0.01

eGFR, IQR, ml/min/1.73 m2

0.96 [0.95–0.97]

< 0.01

*Backward stepwise multi-regression model for an adjusted odds ratio (aOR) for the following relevant factors that includes total Mg concentrations, age, female, body mass index, diabetes, hypertension, chronic kidney disease, heart failure, potassium, sodium, creatinine, estimated glomerular filtration rate, albumin, frusemide, comorbidites ≥ 3, and Mg correction/treatment.